Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 4.71M | 4.09M | 3.48M | 4.69M | 5.94M |
| Total Revenue | 4.71M | 4.09M | 3.48M | 4.69M | 5.94M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.71M | 4.09M | 3.48M | 4.69M | 5.94M |
| SG&A Expenses | 5.62M | 5.41M | 5.25M | 5.05M | 4.89M |
| Depreciation & Amortization | 277.30K | 274.20K | 273.20K | 270.30K | 268.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.62M | 14.98M | 13.44M | 12.94M | 12.52M |
| Operating Income | -11.91M | -10.89M | -9.96M | -8.25M | -6.58M |
| Income Before Tax | -11.60M | -10.53M | -9.56M | -7.95M | -6.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.60 | -10.53 | -9.56 | -7.95 | -6.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.60M | -10.53M | -9.56M | -7.95M | -6.38M |
| EBIT | -11.91M | -10.89M | -9.96M | -8.25M | -6.58M |
| EBITDA | -11.68M | -10.67M | -9.74M | -8.03M | -6.37M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 12.39B | 12.15B | 11.92B | 11.16B | 10.40B |
| Average Diluted Shares Outstanding | 12.39B | 12.15B | 11.92B | 11.16B | 10.40B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |